Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Expectations?
View:
Post by JohnnyYeg on Jan 15, 2025 11:18am

Expectations?

None. Every trial over the last 10 years has had "good safety data." Trial results - interim or later/final (BRACELET-1) - spark some results share price-wise but I only for a day or two.

The ONLY thing that will spark ANY kind of significant share price increase will be a biz dev announcement of a partnership or buyout. I'd be willing to bet a 50% CR from a trial would do little. 

Big Pharma has done more with lesser advanced trials with other biotech devs than anything with ONC. For whatever reason, there seems to be little interest beyond curiosity with BP. Every single quarter ONC is meeting with these analysts, or hobnobbing with industry folk at that conference, or presenting posters there, with no results worth noting. Every. Single. Quarter.

We have a great - a fantastic - idea/product but no one else is excited about it. I mean what more do we need to show... to prove?

Yeah, I'm flabbergasted.
Comment by Lesalpes29 on Jan 15, 2025 11:43am
Well said... uninterested BP at the moment. And ONC trying to survive... until... GL
Comment by venture009 on Jan 15, 2025 11:46am
My take on the current action is that the ATM is being utilized. This conference hasn't yielded any perspective partners, so the only option is raise capital by the only means possible. No one is stepping forward because for the longest time now the conversation, here at least, is we are ready for PIII in manu applications. After this release today the only application is maybe breast cancer ...more  
Comment by Buckhenry on Jan 15, 2025 1:07pm
I bet some of those folks that bought in pre market over a dollar are not happy campers!!
Comment by Buckhenry on Jan 15, 2025 1:14pm
But since price does not matter i guess it's a moot point. 
Comment by Peladawn on Jan 15, 2025 1:08pm
 Venture00zero....if the company was selling shares pre market by the multiple millions, why did the share price rise close to $1.20? One would think the share price would dive during the majority of your alleged "selling" activity.
Comment by venture009 on Jan 15, 2025 1:22pm
They took advantage of a misleading NR. "Regulatory Approval..." cretainly suggest something other moving to enroll a few more people into a PI trial. I am sure Canaccord is helping.  There certainly isn't any enthusiasm for the stock now. If a partner was waiting this would most certainly have been mentioned. How do you explain the volume? Seen too many of these type of ...more  
Comment by Peladawn on Jan 15, 2025 1:29pm
So you're saying whoever bought $30 million worth of shares this morning, wasn't smart enough to properly read the news release?
Comment by canadafan on Jan 15, 2025 1:55pm
Great dialog. At least.  we are talking about Onc & not name calling or random wast of ink. One thing we can all agree on, todays presss release as a headline was  a bit over the top with the firs5 1/2 of the headline. Reading  the whole headline clears that up. The first lines after the headline, give explicit details. Two takes on that many constantly say, mangement does a ...more  
Comment by CMHarring218431 on Jan 15, 2025 1:45pm
Johnny, like I said a couple of days ago..... any substantial news would be preceded by an increase in vol and price. Almost always! Gotta love Noteable's " en mass" claim . Again, I think he is very close to the company and that declaration of his was made to bolster and increase speculation about a buyout during the conference. He"s smarter than that but he has a job to do